External Funding Opportunities
The Gynecologic Cancer Initiative has created a database of external funding opportunities available to researchers. Our team will continue to build and update this database for researchers conducting gynecologic cancer researchers. If you know of an external funding opportunity to add to this database, please email us at info@gynecancerinitiative.ca
Upcoming Funding
Application Deadline | Grant (w/ updated link) | Organization | Amount & Duration |
---|---|---|---|
Ongoing | New Patient and Family Engagement Grant | C+W Partners in Action | $2,500 |
Ongoing | Alliance Grants Option 2 | NSERC | $20,000-$100,000 per year; 1-5 years |
Ongoing | Translational Research Partnership Program 2 | Cancer Research Society | $750,000 per year; 3 years |
TBA (LOI, Full) | Impact Grants | Canadian Cancer Society | |
10/03/2021 (Full) - Expression of Interest not previously needed | OvCAN Priority 3 competition | Ovarian Cancer Canada | Varied; Total funding available is $2.2M between April 2022 and March 2024 |
02/28/2021 (Full) | University of British Columbia | ||
03/04/2021 (Registration); 04/01/2021 (Full) | CIHR | ||
06/23/2021 (Registration) 10/02/2021 (Full Internal) 10/10/2021 (Full External) | CCS/CIHR-ICR Initiative in Primary Cancer Prevention Proof-of-Concept | CCS/CIHR | Up to $200,000; 1 year |
06/22/2021 (Preroposal Internal) 06/29/2021 (Preproposal External) 12/18/2021 (Full Internal) 12/20/2021 (Full External) | CIHR-Operating Grant : TRANSCAN-3 Next generation cancer immunotherapy: targeting the tumour microenvironment | CIHR | Up to $150,000 per year; 3 years |
06/30/2021 (Full Internal) 07/ 06/2021 10:00 am PST 07/08/2021 (Full External) | OCRP Proteogenomics Research Award | US-DoD Ovarian Cancer Research Program F2021 | $800,000 |
Trainee Funding
Application Deadline | Grant (w/ updated link) | Organization | Amount & Duration |
---|---|---|---|
Ongoing | Accelerate Programe | Mitacs | $10,000 per every 4 months; up to 3 years |
12/31/2021 (Full) | Health System Impact Fellowship | CIHR |